Hi there. I understand your concern. Of course a lot of companies are working with immunotherapy.
The company in question is trying to work on the treatment.
I see your concern but the more research the merrier.
As far as srne is concerned they have a huge database for antibodies and they are working on multiple approaches.
They have COVI shield, COVI guard....
They want to neutralize the virus like everybody else.
They are unique in the approach of a COVI shied( a combination of 3 antibodies, they found 2 of them so far, the third will follow soon). They want to attack on multiple fronts: treatment( this is where he said cure), shielding is the most important one because it can be ready by October and will provide a vaccine effect for 3 months. The vaccines now are showing partial and some good response in the early stages. Sorrento is providing us with proven antibodies and 3 of them. This is where it’s excellent.
I hope this helps